A4GNT | Alpha-1,4-N-acetylglucosaminyltransferase | Predicted secreted proteins
| | | | | Tissue enriched |
AADAC | Arylacetamide deacetylase | Enzymes
| | | | | Tissue enhanced |
ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Cancer-related genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
AC012215.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AC021218.2 | Uncharacterized protein | | | | | | Tissue enhanced |
AC079602.1 | | | | | | | Tissue enhanced |
AC106876.2 | Uncharacterized protein | | | | | | Group enriched |
AC138517.1 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACER2 | Alkaline ceramidase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ACY1 | Aminoacylase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ACY3 | Aspartoacylase (aminocyclase) 3 | Enzymes
| | | | | Tissue enhanced |
ADA | Adenosine deaminase | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Tissue enriched |
ADAM28 | ADAM metallopeptidase domain 28 | Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AGR2 | Anterior gradient 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | Mitochondrial proteins
| | | | | Group enriched |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | | | | | | Tissue enhanced |
AKR1B15 | Aldo-keto reductase family 1, member B15 | | | | | | Tissue enhanced |
AKR7A3 | Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | | | | | | Tissue enhanced |
AL162431.1 | Uncharacterized protein | | | | | | Group enriched |
AL354898.1 | | | | | | | Tissue enhanced |
ALDH3A1 | Aldehyde dehydrogenase 3 family, member A1 | Enzymes
| | | | | Tissue enhanced |
ALDOB | Aldolase B, fructose-bisphosphate | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
ALPI | Alkaline phosphatase, intestinal | Enzymes Predicted secreted proteins
| | | | | Group enriched |
AMN | Amnion associated transmembrane protein | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
AMTN | Amelotin | Predicted secreted proteins
| | | | | Group enriched |
ANKRD22 | Ankyrin repeat domain 22 | | | | | | Tissue enhanced |
ANKS4B | Ankyrin repeat and sterile alpha motif domain containing 4B | | | | | | Tissue enhanced |
ANO9 | Anoctamin 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ANXA10 | Annexin A10 | | | | | | Tissue enriched |
ANXA13 | Annexin A13 | Plasma proteins
| | | | | Tissue enhanced |
AOC1 | Amine oxidase, copper containing 1 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
APOBEC1 | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 | | | | | | Group enriched |
AQP10 | Aquaporin 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |
AQP11 | Aquaporin 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
AQP8 | Aquaporin 8 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARHGDIG | Rho GDP dissociation inhibitor (GDI) gamma | | | | | | Tissue enhanced |
ARL14 | ADP-ribosylation factor-like 14 | | | | | | Group enriched |
ASAH2 | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 | Enzymes Predicted secreted proteins
| | | | | Group enriched |